Molecular epidemiology of Serratia marcescens in two hospitals in Gdańsk, Poland, over a 5-year period

Journal of Clinical Microbiology
Lukasz NaumiukJózef Kur

Abstract

The history of the Serratia marcescens population in two hospitals in Danzig, Poland, over a 5-year period was analyzed in a study that combined MIC evaluation, typing by randomly amplified polymorphic DNA (RAPD) analysis and pulsed-field gel electrophoresis, and analysis of extended-spectrum beta-lactamases (ESBLs). We analyzed 354 isolates collected from 341 patients in two teaching hospitals in Danzig, Poland, from 1996 to 2000. The antimicrobial susceptibility profiles varied greatly, and for resistance to newer beta-lactams, probable AmpC cephalosporinase derepression and ESBL production occurred in about 23 and 19% of the isolates, respectively. RAPD typing, by which 69 types were discerned altogether, revealed a high degree of clonal diversity among the populations. However, the four most prevalent types were highly predominant, grouping approximately 71% of the isolates studied. These clones were observed in the two hospitals and were strong contributors to both outbreaks and the background of endemicity of the S. marcescens infections. Some of the strains that were not so widely spread (12 RAPD types; approximately 14% of the isolates) were responsible for several smaller outbreaks, and the remaining isolates represent...Continue Reading

References

Aug 28, 1976·Lancet·J J FarmerR A Bobo
Apr 19, 1979·The New England Journal of Medicine·V L Yu
Dec 1, 1990·Antimicrobial Agents and Chemotherapy·D Billot-KleinE Collatz
May 1, 1986·Infection Control : IC·J F Acar
Nov 22, 1997·Journal of Medical Microbiology·A HejaziF R Falkiner
Dec 1, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F LuzzaroL Pagani
Apr 29, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·P BerthelotP Fargier
Jul 8, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·H Peltroche-LlacsahuangaG Haase
Jan 11, 2001·FEMS Microbiology Letters·T G PattonS S Crupper
Jun 23, 2001·The Journal of Antimicrobial Chemotherapy·D M LivermoreK P Shannon
Dec 12, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Gniadkowski
Jan 5, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·P VillariA Scarcella
Jan 8, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David M Livermore
May 6, 2003·Diagnostic Microbiology and Infectious Disease·Wen-Liang YuRonald N Jones
Jul 16, 2003·Current Opinion in Infectious Diseases·Rafael CantónFernando Baquero
Oct 9, 2003·Journal of Clinical Microbiology·Lin-Hui SuUNKNOWN Infection Control Group

❮ Previous
Next ❯

Citations

Oct 26, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K B LauplandJ D D Pitout
May 21, 2008·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Rumyana MarkovskaAdolf Bauernfeind
Oct 7, 2011·Clinical Microbiology Reviews·Steven D Mahlen
Jan 22, 2010·Indian Journal of Pathology & Microbiology·Meher RizviAbida Malik
Nov 1, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Rumyana Donkova MarkovskaIvan Gergov Mitov
Jul 30, 2014·Genome Biology and Evolution·Atsushi IguchiTetsuya Hayashi
Apr 18, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Rima BatahJean-Marc Rolain
Feb 28, 2006·Scandinavian Journal of Infectious Diseases·Spyros PournarasAntonios N Maniatis
Dec 7, 2013·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Rumyana MarkovskaAdolf Bauernfeind
Feb 23, 2019·International Journal of Environmental Research and Public Health·Maria Luisa CristinaAnna Maria Spagnolo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.